Office Action Predictor
Application No. 18/390,596

Thermally expandable compositions comprising wax

Non-Final OA §102
Filed
Dec 20, 2023
Examiner
COONEY, JOHN M
Art Unit
1765
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Henkel AG & CO. Kgaa
OA Round
1 (Non-Final)
62%
Grant Probability
Moderate
1-2
OA Rounds
3y 4m
To Grant
88%
With Interview

Examiner Intelligence

62%
Career Allow Rate
649 granted / 1043 resolved
Without
With
+26.3%
Interview Lift
avg trend
3y 4m
Avg Prosecution
37 pending
1080
Total Applications
career history

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
43.2%
+3.2% vs TC avg
§102
16.0%
-24.0% vs TC avg
§112
26.6%
-13.4% vs TC avg
Black line = Tech Center average estimate • Based on career data

Office Action

§102
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I. in the reply filed on 11/10/2025 is acknowledged. Claims 8 & 9 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected grouping of invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 11/10/2025. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-7 and 10 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Zhang et al.(20200317881). Zhang et al. discloses peroxidically crosslinking ethylene-vinyl acetate (EVA) copolymer; at least one foaming agent; at least one peroxide compound, and wax which meet the requirements of applicants’ claims and amounts meeting the requirements of the claims {see abstract, paras [0031]-[0051], the Examples, including Example 4, and Table 1A}. [Note: Example 4 - Zhang et al. also discloses a composition comprising 45% by weight of Elvax 460 (MFI 2.5), 2% by weight of Elvax 260 (MFI 6), 15% by weight of OBSH, 6% by weight of peroxide and 2.2% by weight of Microsere 5999A wax. Regarding claim 3 , peroxides as claimed are disclosed {paras [0034] and [0035] and Example 4}. Regarding claim 4, foaming agents as claimed are disclosed {paras [0031]-[0033]}. Regarding claim 5, waxes as claimed are disclosed and preferred {para [0051] and Example 4}. Regarding claim 6, in that the products of Zhang et al. are combined compositions and claims are directed towards finally formed compositions, they are not distinguished by the alternative embodiment of this claim that components, particularly (b), (c) and (d), may be included in a batch. Regarding claims 7 and 10, filled, molded parts are formed that are sufficient to meet the functions recited by these claims {para [0002] and claims}. The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Vignola et al., Walton et al. and Lieber et al. are cited for their disclosure of relevant crosslinkable resins and materials used in the associated arts. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to John Cooney whose telephone number is 571-272-1070. The examiner can normally be reached on M-F from 9 to 6. If attempts to reach the examiner by telephone are unsuccessful, the examiner's supervisor, Heidi Riviere Kelley, can be reached on 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOHN M COONEY/Primary Examiner, Art Unit 1765
Read full office action

Prosecution Timeline

Dec 20, 2023
Application Filed
Dec 12, 2025
Non-Final Rejection — §102
Mar 31, 2026
Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology. Study what changed to get past this examiner.

Patent 12595348
High-strength eTPU
2y 5m to grant Granted Apr 07, 2026
Patent 12595332
PREPARATION OF POLYURETHANE SYSTEMS
2y 5m to grant Granted Apr 07, 2026
Patent 12595347
HYDROFLUORO OLEFIN PROPELLANT IN A POLYURETHANE FOAM COMPOSITION
2y 5m to grant Granted Apr 07, 2026
Patent 12583992
COMPOSITE BODY
2y 5m to grant Granted Mar 24, 2026
Patent 12570823
POLYURETHANE FOAM COMPOSITION CONTAINING TPU POWDER AND MANUFACTURING METHOD OF SHOE INSOLE USING THE SAME
2y 5m to grant Granted Mar 10, 2026

AI Strategy Recommendation

Click below to generate an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
62%
Grant Probability
88%
With Interview (+26.3%)
3y 4m
Median Time to Grant
Low
PTA Risk
Based on 1043 resolved cases by this examiner